American Diabetes Association’s 84th Scientific Sessions: Human Cell Design presents its latest cAMP assay Scientists from Human Cell Design participated in the American Diabetes Association’s 84th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention, and care in Orlando (USA). During the event, our team presented how our rapid and high-resolution cAMP assay can enhance the evaluation
Reveal your drug’s anti-inflammatory and beta cell protection potential Using Endoc-BH5® cells, the Cytokine-Mediated Human Beta Cell Inflammation Assay replicates in vitro the clinically observed response of human pancreatic beta cells to cytokine-induced inflammation process observed in Type 2 and Type 1 Diabetes. Key advantages: Discover how this assay will enable you to evaluate the anti-inflammatory and beta cell protection
Revolutionize your Autoimmune-mediated T1D Research: HLA-A2 βH5® Cell Line Open new avenue using a unique clinically relevant cell model. HLA-A2 EndoC-βH5® is a new human pancreatic beta cell line that has been specifically designed to recapitulate pathological Beta Cell killing and Dysfunction observed in autoimmune Type 1 Diabetes patients. HLA-A2 EndoC-βH5® cell line offers you: Robustness: A stable model from
Human Cell Design scientists are proud to present at the 59th EASD two new and innovative human T1D & T2D cell models Hamburg, October 2-6, 2023 This year many EASD talks demonstrated the relevance of Endoc-βH5® human beta cells as the one of Arnaud Dance from the Dr. Anne Bonnefond group. In parallel, Human Cell design scientists are proud to
Don’t always wait for human pancreatic islet samples. EndoC-βH5 is a flexible solution of human beta cells that can be used at any time. See here an illustration of the use of EndoC-βH5® cells from thawing to functional assay (e.g. glucose stimulated insulin secretion, GSIS). EndoC-βH5® cells are fully mature human pancreatic beta cells that exhibit characteritics of native beta cell (i.e.